Mawer Investment Management’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-51,912	Closed	-$7.81M	–	111
2025 Q1	$7.81M	Buy	51,912 +5,283	+11%	+$886K	0.04%	97
2024 Q4	$8.61M	Buy	46,629 +5,769	+14%	+$1.11M	0.04%	93
2024 Q3	$8.05M	Sell	40,860 -32,693	-44%	-$6.79M	0.04%	97
2024 Q2	$15.2M	Buy	73,553 +27,954	+61%	+$6.33M	0.07%	79
2024 Q1	$12.4M	Buy	45,599 +19,574	+75%	+$4.67M	0.06%	78
2023 Q4	$6.15M	Buy	26,025 +7,014	+37%	+$1.38M	0.03%	78
2023 Q3	$3.73M	Buy	19,011 +1,744	+10%	+$358K	0.02%	83
2023 Q2	$3.63M	Buy	17,267 +1,434	+9%	+$285K	0.02%	81
2023 Q1	$3.2M	Buy	15,833 +500	+3%	+$113K	0.02%	84
2022 Q4	$3.34M	Buy	15,333 +2,766	+22%	+$604K	0.02%	85
2022 Q3	$2.47M	Buy	12,567 +3,644	+41%	+$787K	0.02%	81
2022 Q2	$1.91M	Buy	8,923 +2,951	+49%	+$721K	0.01%	81
2022 Q1	$1.7M	Buy	5,972 +3,040	+104%	+$937K	0.01%	85
2021 Q4	$1.1M	Buy	2,932 +1,919	+189%	+$746K	0.01%	96
2021 Q3	$418K	Buy	+1,013	New	+$421K	﹤0.01%	98